Investigation into alternative testing methodologies for characterization of influenza virus vaccine
Authors:
Open Access
- 21 May 2015
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 11 (7) , 1673-1684
Abstract
The objective of this study was to explore various testing methodologies suitable for characterizing sedimented or agglomerated material. To model this, bioCSL's split influenza virus vaccine, Fluvax® was utilized. The investigation was conducted on 5 dispensed lots of commercially manufactured vaccine, formulated for the 2013 Southern Hemisphere season. Vaccine syringes were initially inspected by visual tests; the material was then aseptically pooled for characterization assessment by microscopy and several agglomeration assays. All syringes passed bioCSL's description test where any fine or large sized particles of sediment observed in the vaccine were resuspended upon shaking; inverted light microscopy verified that the sediment morphology was consistent with influenza vaccine. Electron microscopic examination of pooled vaccine material demonstrated the presence of typical influenza structures including split virus, virosomes, whole virus particles and agglomerates. An optical density turbidity assay revealed relatively high protein recoveries in the vaccine supernatant post-centrifugation treatment, thus indicative of a well-dispersed vaccine formulation. This was corroborated by particle sizing analysis using dynamic light scattering which generated reproducible volume particle size distributions of a polydisperse nature. Ultraviolet-visible absorbance profiles further confirmed the presence of some agglomerated material. Data from all methods demonstrated consistent results between all batches of vaccine. Therefore, this investigation revealed the suitability and usefulness of the various methodologies in characterizing the appearance of agglomerated vaccine material. It is suggested that such methods may be applicable and beneficial for the development of a wider spectrum of heterogeneous and agglomerated formulations to provide safe, efficacious and superior quality biopharmaceutical products.Keywords
This publication has 23 references indexed in Scilit:
- Dual effects of Tween 80 on protein stabilityInternational Journal of Pharmaceutics, 2008
- Field-flow fractionation and biotechnologyTrends in Biotechnology, 2005
- Aggregation Events Occur Prior to Stable Intermediate Formation during Refolding of Interleukin 1βBiochemistry, 1999
- MODERN APPLICATIONS OF ANALYTICAL ULTRACENTRIFUGATIONAnnual Review of Biophysics, 1999
- New revolutions in the evolution of analytical ultracentrifugationCurrent Opinion in Structural Biology, 1996
- Rapid protein separation and diffusion coefficient measurement by frit inlet flow field‐flow fractionationProtein Science, 1993
- Field-Flow Fractionation: Analysis of Macromolecular, Colloidal, and Particulate MaterialsScience, 1993
- A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in ChildrenThe Journal of Infectious Diseases, 1977
- Fractionation of the influenza virus with the object of producing subunit vaccinePostgraduate Medical Journal, 1973
- Conformation of proinsulin. Comparison of insulin and proinsulin self-association at neutral pHBiochemistry, 1972